Akebia Therapeutics stock price took a fall of -5.62% on Friday
(Updated on Dec 03, 2021)

The Akebia Therapeutics stock price fell by -5.62% on the last day (Friday, 3rd Dec 2021) from $2.67 to $2.52. During the day the stock fluctuated 7.57% from a day low at $2.51 to a day high of $2.70. The price has been going up and down for this period, and there has been a -8.7% loss for the last 2 weeks. Volume has increased on the last day by 227 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $8.78 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.63) are considered to be a "second chance" to get out. According to the fan-theory $1.97 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Akebia Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.65 and $2.84. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, November 03, 2021, and so far it has fallen -24.55%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.19 between high and low, or 7.57%. For the last week, the stock has had a daily average volatility of 6.40%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Akebia Therapeutics stock A Buy?

Akebia Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.354

Remember To Visit Our YouTube Channel